Eli Lilly on Tuesday lowered its sales forecast because demand for its weight-loss and diabetes ...
Merck announced Wednesday that it has secured the rights to an experimental weight-loss pill from ...
Eli Lilly on Tuesday lowered its sales forecast because demand for its weight-loss and diabetes ...
Merck announced Wednesday that it has secured the rights to an experimental weight-loss pill from ...
Our website uses cookies to improve your experience. Learn more about: Cookie Policy